Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
QuintilesIMS
Moodys
Express Scripts
Argus Health
Teva
Queensland Health
Merck
Boehringer Ingelheim

Generated: January 22, 2019

DrugPatentWatch Database Preview

Us Pharm Holdings Company Profile

« Back to Dashboard

What is the competitive landscape for US PHARM HOLDINGS, and what generic and branded alternatives to US PHARM HOLDINGS drugs are available?

US PHARM HOLDINGS has ten approved drugs.



Summary for Us Pharm Holdings
US Patents:0
Tradenames:10
Ingredients:8
NDAs:10

Drugs and US Patents for Us Pharm Holdings

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Us Pharm Holdings LASIX furosemide TABLET;ORAL 016273-001 Approved Prior to Jan 1, 1982 AB RX Yes No ➤ Sign Up ➤ Sign Up
Us Pharm Holdings NORPRAMIN desipramine hydrochloride TABLET;ORAL 014399-005 Approved Prior to Jan 1, 1982 AB RX Yes Yes ➤ Sign Up ➤ Sign Up
Us Pharm Holdings ANZEMET dolasetron mesylate TABLET;ORAL 020623-002 Sep 11, 1997 DISCN Yes No ➤ Sign Up ➤ Sign Up
Us Pharm Holdings DEMEROL meperidine hydrochloride INJECTABLE;INJECTION 005010-009 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
Us Pharm Holdings TRENTAL pentoxifylline TABLET, EXTENDED RELEASE;ORAL 018631-001 Aug 30, 1984 DISCN Yes No ➤ Sign Up ➤ Sign Up
Us Pharm Holdings CLAFORAN IN DEXTROSE 5% IN PLASTIC CONTAINER cefotaxime sodium INJECTABLE;INJECTION 050596-004 May 20, 1985 DISCN No No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for Us Pharm Holdings

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Us Pharm Holdings NORPRAMIN desipramine hydrochloride TABLET;ORAL 014399-005 Approved Prior to Jan 1, 1982 3,454,698 ➤ Sign Up
Us Pharm Holdings LASIX furosemide TABLET;ORAL 016273-003 Approved Prior to Jan 1, 1982 4,324,779 ➤ Sign Up
Us Pharm Holdings NORPRAMIN desipramine hydrochloride TABLET;ORAL 014399-001 Approved Prior to Jan 1, 1982 3,454,698 ➤ Sign Up
Us Pharm Holdings LASIX furosemide TABLET;ORAL 016273-002 Approved Prior to Jan 1, 1982 4,324,779 ➤ Sign Up
Us Pharm Holdings ANZEMET dolasetron mesylate INJECTABLE;INJECTION 020624-002 Sep 11, 1997 4,906,755 ➤ Sign Up
Us Pharm Holdings NORPRAMIN desipramine hydrochloride TABLET;ORAL 014399-005 Approved Prior to Jan 1, 1982 3,454,554 ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Moodys
Dow
Federal Trade Commission
Citi
Baxter
Fuji
Chinese Patent Office
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.